CH617350A5 - Process for the preparation of HB-Ag vaccines with high-level antibody formation - Google Patents
Process for the preparation of HB-Ag vaccines with high-level antibody formation Download PDFInfo
- Publication number
- CH617350A5 CH617350A5 CH1636974A CH1636974A CH617350A5 CH 617350 A5 CH617350 A5 CH 617350A5 CH 1636974 A CH1636974 A CH 1636974A CH 1636974 A CH1636974 A CH 1636974A CH 617350 A5 CH617350 A5 CH 617350A5
- Authority
- CH
- Switzerland
- Prior art keywords
- solution
- titer
- aqueous solution
- vaccines
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1161774A JPS5523254B2 (fr) | 1974-01-28 | 1974-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH617350A5 true CH617350A5 (en) | 1980-05-30 |
Family
ID=11782869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1636974A CH617350A5 (en) | 1974-01-28 | 1974-12-10 | Process for the preparation of HB-Ag vaccines with high-level antibody formation |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS5523254B2 (fr) |
CA (1) | CA1023662A (fr) |
CH (1) | CH617350A5 (fr) |
DE (1) | DE2440926C3 (fr) |
FR (1) | FR2258864B1 (fr) |
GB (1) | GB1462298A (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4017360A (en) * | 1975-05-14 | 1977-04-12 | Merck & Co., Inc. | Method for purifying hepatitis B antigen |
GB1571829A (en) | 1976-04-06 | 1980-07-23 | Lafon Labor | Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds |
JPS591981B2 (ja) * | 1976-08-27 | 1984-01-14 | 株式会社ミドリ十字 | HBs抗体検出用受身赤血球凝集試験用担体の製造方法 |
US4639371A (en) * | 1984-10-02 | 1987-01-27 | New York Blood Center, Inc. | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
-
1974
- 1974-01-28 JP JP1161774A patent/JPS5523254B2/ja not_active Expired
- 1974-08-14 CA CA206,978A patent/CA1023662A/fr not_active Expired
- 1974-08-15 GB GB3604674A patent/GB1462298A/en not_active Expired
- 1974-08-27 FR FR7429291A patent/FR2258864B1/fr not_active Expired
- 1974-08-27 DE DE2440926A patent/DE2440926C3/de not_active Expired
- 1974-12-10 CH CH1636974A patent/CH617350A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS50105817A (fr) | 1975-08-20 |
CA1023662A (fr) | 1978-01-03 |
FR2258864A1 (fr) | 1975-08-22 |
DE2440926B2 (de) | 1978-04-06 |
JPS5523254B2 (fr) | 1980-06-21 |
GB1462298A (en) | 1977-01-19 |
DE2440926C3 (de) | 1978-11-30 |
FR2258864B1 (fr) | 1978-06-30 |
DE2440926A1 (de) | 1975-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2751717C2 (fr) | ||
EP0659767B2 (fr) | Procédé de préparation d'un concentré d'immunoglobuline G anti-D et compositions pharmaceutiques qui le contiennent | |
DE2936047A1 (de) | Verfahren zur herstellung eines intravenoes verabreichbaren antikoerperhaeltigen immunglobulinpraeparates und danach hergestellte praeparate | |
DE2459291A1 (de) | Verfahren zur gleichzeitigen herstellung von drei therapeutisch verwendbaren produkten aus einem ausgangsmaterial | |
CH639854A5 (de) | Gefriergetrocknetes natives gammaglobulin-praeparat zur intravenoesen verabreichung und verfahren zu seiner herstellug. | |
DE2624815B2 (de) | Herstellung einer injizierbaren, stromafreien und von Plasmaproteinen freien Hämoglobinlösung | |
DE2433209A1 (de) | Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate | |
DE2127159A1 (de) | Verfahren zur Fraktionierung von Plasmaproteinen | |
DE2734150C3 (de) | Verfahren zur Herstellung von Human-Lysozympräparaten | |
DE2403994A1 (de) | Herstellung von antisera | |
DE2658170A1 (de) | Arzneimittel zur behandlung der durch den hepatitisvirus b ausgeloesten akuten oder chronischen infektionen | |
DE3152621C2 (fr) | ||
DE2835843A1 (de) | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung | |
CH617350A5 (en) | Process for the preparation of HB-Ag vaccines with high-level antibody formation | |
DE3604947C2 (fr) | ||
DE2440927C3 (de) | Injizierbarer inaktivierter Impfstoff gegen Hepatitis B | |
DE2639012C3 (de) | Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen | |
DE2703620C2 (de) | Verfahren zur Herstellung eines Konzentrats des Antihämophiliefaktors | |
DE19600939C1 (de) | Verfahren zur Trennung von IgG und IgA | |
DE2748520C2 (fr) | ||
DE2515666C3 (de) | Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat | |
DE2415079C3 (de) | Verfahren zum Isolieren von Albumin aus Blutplasma | |
DE2532276C3 (de) | Verfahren zur Reinigung von Human-Antilymphozytenserum | |
DE2409650A1 (de) | Waessrige haptoglobinloesungen, verfahren zu ihrer herstellung und arzneimittel | |
DE2733923A1 (de) | Verfahren zur gewinnung von humanalbumin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |